Amalgamated Bank Sells 178 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Amalgamated Bank decreased its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report) by 1.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,668 shares of the semiconductor company’s stock after selling 178 shares during the period. Amalgamated Bank’s holdings in Axcelis Technologies were worth $2,392,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of the stock. Chartwell Investment Partners LLC purchased a new stake in Axcelis Technologies in the third quarter worth about $437,000. Barclays PLC raised its stake in Axcelis Technologies by 267.0% during the 3rd quarter. Barclays PLC now owns 100,409 shares of the semiconductor company’s stock worth $16,372,000 after acquiring an additional 73,053 shares during the period. Quantbot Technologies LP purchased a new position in Axcelis Technologies during the third quarter valued at approximately $910,000. JPMorgan Chase & Co. boosted its position in shares of Axcelis Technologies by 61.7% in the second quarter. JPMorgan Chase & Co. now owns 174,913 shares of the semiconductor company’s stock worth $32,067,000 after purchasing an additional 66,753 shares during the period. Finally, Assenagon Asset Management S.A. increased its stake in shares of Axcelis Technologies by 284.0% in the third quarter. Assenagon Asset Management S.A. now owns 23,946 shares of the semiconductor company’s stock worth $3,904,000 after purchasing an additional 17,710 shares in the last quarter. 88.93% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ACLS. B. Riley Financial dropped their target price on shares of Axcelis Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Friday. B. Riley decreased their target price on Axcelis Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Friday. Finally, Bank of America downgraded Axcelis Technologies from a “buy” rating to a “neutral” rating in a research note on Friday, December 15th. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $176.43.

Get Our Latest Research Report on ACLS

Axcelis Technologies Stock Up 2.5 %

NASDAQ ACLS opened at $125.32 on Monday. The stock has a 50 day moving average price of $128.00 and a 200-day moving average price of $147.84. Axcelis Technologies, Inc. has a one year low of $105.28 and a one year high of $201.00. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.69 and a current ratio of 3.79. The company has a market capitalization of $4.10 billion, a P/E ratio of 16.87, a P/E/G ratio of 1.00 and a beta of 1.69.

Axcelis Technologies (NASDAQ:ACLSGet Free Report) last issued its quarterly earnings data on Thursday, February 8th. The semiconductor company reported $2.15 EPS for the quarter, topping analysts’ consensus estimates of $1.98 by $0.17. The business had revenue of $310.29 million during the quarter, compared to analysts’ expectations of $297.92 million. Axcelis Technologies had a net margin of 21.78% and a return on equity of 31.66%. The business’s revenue was up 16.6% on a year-over-year basis. During the same period last year, the company posted $1.71 EPS. As a group, equities analysts predict that Axcelis Technologies, Inc. will post 7.25 EPS for the current fiscal year.

Axcelis Technologies Profile

(Free Report)

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.

Read More

Want to see what other hedge funds are holding ACLS? Visit to get the latest 13F filings and insider trades for Axcelis Technologies, Inc. (NASDAQ:ACLSFree Report).

Institutional Ownership by Quarter for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with's FREE daily email newsletter.